Phase II Multicenter Trial of Voreloxin as Second-Line Therapy in Chemotherapy-Sensitive or Refractory Small Cell Lung Cancer
Krug, Lee M., Crawford, Jeffrey, Ettinger, David S., Shapiro, Geoffrey I., Spigel, David, Reiman, Tony, Temel, Jennifer S., Michelson, Glenn C., Young, Donald Y., Hoch, Ute, Adelman, Daniel C.Volume:
6
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1097/JTO.0b013e318200e509
Date:
February, 2011
File:
PDF, 81 KB
english, 2011